Hey folks, here with a big update on the Apple Watch import drama. Remember that whole Masimo patent tiff that put the brakes on the Series 9 and Ultra 2? Well, good news, bad news situation brewing.

US Customs Decision

First, the good news: U.S. Customs just ruled that Apple's proposed redesign of the Watch Series 9 and Ultra 2 sidesteps that nasty import ban. Seems they found a way to tweak the tech without infringing on Masimo's patents. This means we could see those shiny new watches on shelves again soon, folks. This redesign probably means we won't see those fancy new blood oxygen features – at least not in their current form. And that's where things get juicy.

Masimo Settlement

Settling with Masimo and admitting tech pilfering isn't exactly Apple's style. They've always prided themselves on clean-room engineering, and this whole kerfuffle could tarnish their shiny image. Plus, there's the risk of legal dominoes – other companies might come sniffing around for their pound of patent flesh.

So, what's next? Apple could roll out their redesigned Watches sans blood oxygen, which wouldn't exactly set the tech world on fire. Or, they could fight Masimo tooth and nail in court, a process that could drag on for years. My money's on the latter – Apple ain't one to back down from a good scrap.

CEO Tim Cook is comfortable with the numbers for Apple Watch

Apple is well-known not to reveal their sales figures for each product. This has left market experts wondering if the Apple Watch is a hit or a miss. The IDC has reported that they are under what the company expected. Apple's CEO, Tim Cook says that they are "just fine".

The market for wearable technology is small. There are only 4 companies. The most popular competitor is FitBit. While we don't know the sales numbers, we do know that Apple has shipped over 70% fewer units in the last year.